Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test
Shots:
- The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics- metabolomics- and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes- giving doctors the ability to prescribe more precise anti-obesity treatments
- The study showed that phenotype-specific obesity resulted in nearly double the weight loss over the treatment course of 1yr.
- Phenomix has identified the four primary phenotypes i.e Hungry Brain- Hungry Gut- Emotional Hunger- and Slow Burn that encompass more than 90% of obesity cases. The company expects the launch of the MyPhenome test in 2021- once its CLIA laboratory process is complete
Ref: BUSINESS WIRE | Image: Phenomix
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com